-
ABOUT USSSY Group Limited is a large high-tech pharmaceutical enterprise with coordinated development of R&D and industrialization in multiple fields such as new drugs, generic drugs, characteristic APIs
-
INNOVATIONSSY Group Limited has built a relatively perfect scientific research and innovation system with the development mode of “production, learning, research, and application” of multi-disciplinary integration and multi-directional combination.
-
RECRUITIt has established high-level innovation platforms such as engineering laboratory and technology research center jointly with Chinese Academy of Sciences, and now has nearly 400 high-level talents in drug research, analysis and clinical research.
-
SUBSIDIARIESThe company has a diversified business development pattern of R&D, production and export of new drugs, generic drugs, characteristic APIs, advanced finished pharmaceutical products, biological preparations and pharmaceutical packaging materials.
-
CONTACTWe will continue to strengthen innovation-driven development, will vigorously encourage the integration of production and research, strengthen and improve the five domains: new drugs, biological drugs, traditional Chinese medicine, generic drugs and APIs
Shijiazhuang Sihua Pharmaceutical Group Holds 2024 Policy and Goal Launch Conference
Category:
发布时间：2024-01-02
【概要描述】
With the drumbeat signaling the start of a new journey, we set forth with heads held high and strides full of confidence. On December 30–31, 2023, Shijiazhuang Sihua Pharmaceutical Group solemnly convened its 2024 Policy and Target Launch Conference. Leaders of the Group, including Qu Jiguang, Su Xuejun, and Wu Hengyao, together with more than 200 mid- and senior-level managers from the Group’s various centers, business units, and subsidiaries, gathered to jointly map out the Group’s ambitious development blueprint for the year ahead.
With the drumbeat signaling the start of a new journey, we set forth with heads held high and strides full of confidence. On December 30–31, 2023, Shijiazhuang Sihua Pharmaceutical Group solemnly convened its 2024 Policy and Objective Launch Conference. Leaders of the Group, including Qu Jiguang, Su Xuejun, and Wu Hengyao, together with more than 200 mid- and senior-level managers from the Group’s various centers, business units, and subsidiaries, gathered to jointly map out the Group’s ambitious development blueprint for the year ahead. The conference was chaired by Han Shuqin, Executive President of the Group.
At the meeting, Group President Wu Hengyao provided an overview of the preparation of the 2024 policy objectives.
Thirty-six heads of the Group’s centers, business units, and subsidiaries each delivered a detailed report on the achievement of the 2023 strategic objectives, the 2024 targets and specific implementation measures, innovative initiatives, and project timelines, followed by consolidated feedback and guidance from Group leadership.
Group President Wu Hengyao read out the decision on awarding projects and departments that made outstanding contributions in 2023. Representatives of the projects and departments receiving the Outstanding Contribution Commendation then took to the stage one after another to receive their plaques from Group leaders Qu Jiguang and Su Xuejun, amid warm applause from the entire audience in celebration.
Amid warm applause, Qu Jiguang, Chairman of the Group’s Board of Directors, delivered a speech. He noted that 2023 marked the first year of economic recovery and growth following the three-year pandemic. Despite challenging conditions such as subdued expectations in the pharmaceutical market and insufficient effective demand, the Group’s employees rallied together, worked diligently and pragmatically, addressed weaknesses, strengthened weak areas, consolidated foundational strengths, and leveraged competitive advantages, thereby firmly seizing the initiative for development. As a result, key economic indicators reached the highest levels in the Group’s history, and innovative, high-quality development ascended to a new stage, enabling the Group to present a highly satisfactory report card on the occasion of its 75th anniversary.
Qu Jiguang pointed out that 2024 marks the 75th anniversary of the founding of the People’s Republic of China and is also a pivotal year for the implementation of the Group’s 14th Five-Year Plan, making it critically important to deliver strong performance across all aspects of the Group’s operations. All levels of the Group must fully, accurately, and comprehensively apply the new development philosophy; further align thinking, bolster confidence, clarify objectives, enforce accountability, and forge synergy. The focus of operational efforts should be squarely on strengthening two key growth engines—high-quality research and development and market expansion—while continuously deepening reforms of operational mechanisms, fostering and expanding new drivers of productivity, and driving both qualitative improvements in performance and robust quantitative growth across the Group. In doing so, we will strive to usher in a new phase of innovative, high-quality development for the Group.
To ensure the successful execution of the Group’s operations in 2024 and beyond, Qu Jiguang outlined the following four key priorities: First, consolidate the foundation for innovation and elevate its level. It is imperative to firmly uphold the “product-first” philosophy, focus on the most critical and urgent product categories driven by market demand, and prioritize breakthroughs in pioneering new products. At the same time, we must conduct basic research with greater scientific rigor and meticulousness, balancing project development efficiency with quality, and fostering deep integration among the innovation chain, product chain, and value chain. Second, adopt a multi-pronged approach to translate innovation strengths into market and development advantages. We should closely align with market needs and the Group’s R&D and innovation implementation efforts, seize opportunities presented by national and local centralized procurement initiatives, intensify both “going global” and “bringing in” strategies, and coordinate domestic and international markets and resources. By addressing shortcomings in decision-making capability, talent pool strength, product competitiveness, and strategic planning, we will strive to forge a new path of marketing-driven, high-quality development. Third, firmly embrace the principle of “building the enterprise through talent,” leveraging our talent advantage to aggregate broader developmental strengths. We need to systematically develop and strengthen teams of high-level professionals, managerial talent, and skilled workers, fully harnessing Shijiazhuang’s “15 New Talent Policies” as well as the Group’s innovative talent management and compensation reform mechanisms to deliver a comprehensive, integrated talent-development strategy. Fourth, take the promotion of new industrialization as a key lever to continuously reinforce the enterprise’s foundational support. Focusing on intelligent, integrated, and green transformation, we must ensure that newly launched infrastructure projects and production-modification and upgrade initiatives incorporate and draw upon cutting-edge technological advances and proven management practices. By continuously optimizing and upgrading the product mix, we will inject robust momentum into the Group’s sustainable development.
The new era inspires us to forge ahead, and the new blueprint fills us with hope. The meeting called on all employees of the Group to continue upholding the spirit of responsibility—“achieving enterprise prosperity through hard work; if not us, who else?”—to unite as one, and to approach our tasks with the earnestness of diligent action, the determination to tackle challenges head-on, the skill to execute effectively, and the perseverance to sustain progress over the long term. By staying firmly focused on our new goals and delivering new results, we will ensure the successful implementation of the Group’s key objectives for 2024 and strive to write a new chapter in the Group’s innovative, high-quality development.
Keywords:
Recommended News
Share to
SERVICE HOTLINE
Address: Shimen Building, No. 8 Xingye Street, Shijiazhuang Economic and Technological Development Zone
Tel.: +86-311-67167130
Email: office@sjzsiyao.com
Mobile site
E code
Non-Commercial (Filing) – 2025-0091